.BETA.-(((3R)-3-(((1,1-DIMETHYLETHOXY)CARBONYL)AMINO)-1-OXO-4-(2,4,5-TRIFLUOROPHENYL)BUTYL)AMINO)-2,4,5-TRIFLUOROBENZENEBUTANOIC ACID, (.BETA.R)-
UNII 3J932MNA4N

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-(((3r)-3-(((1,1-dimethylethoxy)carbonyl)amino)-1-oxo-4-(2,4,5-trifluorophenyl)butyl)amino)-2,4,5-trifluorobenzenebutanoic Acid, (.beta.r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3J932MNA4N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2379621-81-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3J932MNA4N

CAS Registry Number

2379621-81-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-(((3R)-3-(((1,1-DIMETHYLETHOXY)CARBONYL)AMINO)-1-OXO-4-(2,4,5-TRIFLUOROPHENYL)BUTYL)AMINO)-2,4,5-TRIFLUOROBENZENEBUTANOIC ACID, (.BETA.R)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H26F6N2O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LKNYTZQMJYISOQ-HUUCEWRRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

154730228

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc(C[C@H](CC(N[C@H](Cc2cc(F)c(F)cc2F)CC(=O)O)=O)NC(=O)OC(C)(C)C)c(cc1F)F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-(((3r)-3-(((1,1-dimethylethoxy)carbonyl)amino)-1-oxo-4-(2,4,5-trifluorophenyl)butyl)amino)-2,4,5-trifluorobenzenebutanoic Acid, (.beta.r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.